Figure 3. Effects on VSMCs inflammation.
(A) Effects of control, Ang-(1–7) (100 nmol/L), Ang II (100 nmol/L), Ang-(1–7)+Ang II, A-779 (100 nmol/L), A-779+Ang-(1–7)+Ang II on MCP-1, VCAM-1 and IL-1β protein expressions in VSMCs; (B) effects of A-779 (100 nmol/L) or losartan (100 nmol/L) on the MCP, VCAM-1 and IL-1β protein expressions or Ang II (100 nmol/L) induced inflammation response in VSMCs. Values are mean ± SE. *P < 0.05 vs. control; †P < 0.05 vs. Ang II. n = 3 for each group.